Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

1.

Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.

Di Lorenzo G, De Placido S.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):11-34. Review.

PMID:
16569343
[PubMed - indexed for MEDLINE]
2.

Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.

Prezioso D, Galasso R, Di Martino M, Iapicca G, Annunziata E, Iacono F.

Anticancer Res. 2007 Mar-Apr;27(2):1095-104. Review.

PMID:
17465249
[PubMed - indexed for MEDLINE]
Free Article
3.

Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.

Di Lorenzo G, Autorino R, De Laurentiis M, Bianco R, Lauria R, Giordano A, De Sio M, D'Armiento M, Bianco AR, De Placido S.

Tumori. 2003 Jul-Aug;89(4):349-60. Review.

PMID:
14606635
[PubMed - indexed for MEDLINE]
4.

New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.

Sava T, Basso U, Porcaro A, Cetto GL.

Expert Rev Anticancer Ther. 2005 Feb;5(1):53-62. Review.

PMID:
15757438
[PubMed - indexed for MEDLINE]
5.

Second-line chemotherapy for advanced hormone-refractory prostate cancer.

Garmey EG, Sartor O, Halabi S, Vogelzang NJ.

Clin Adv Hematol Oncol. 2008 Feb;6(2):118-22, 127-32. Review.

PMID:
18347563
[PubMed - indexed for MEDLINE]
6.

Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.

Berry W, Eisenberger M.

Oncologist. 2005;10 Suppl 3:30-9. Review.

PMID:
16368869
[PubMed - indexed for MEDLINE]
Free Article
7.

Chemotherapy for hormone-refractory prostate cancer.

Shelley M, Harrison C, Coles B, Staffurth J, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005247. Review.

PMID:
17054249
[PubMed - indexed for MEDLINE]
8.

Treatment options in hormone-refractory prostate cancer: current and future approaches.

Harris KA, Reese DM.

Drugs. 2001;61(15):2177-92. Review.

PMID:
11772129
[PubMed - indexed for MEDLINE]
9.

Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives.

Autorino R, Di Lorenzo G, Damiano R, De Placido S, D'Armiento M.

Urol Int. 2003;70(1):1-14. Review.

PMID:
12566808
[PubMed - indexed for MEDLINE]
10.

Treatment options in hormone-refractory metastatic prostate carcinoma.

Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E.

Tumori. 2004 Nov-Dec;90(6):535-46. Review.

PMID:
15762353
[PubMed - indexed for MEDLINE]
11.

Treatment of hormone refractory prostate cancer.

Knox JJ, Moore MJ.

Semin Urol Oncol. 2001 Aug;19(3):202-11. Review.

PMID:
11561988
[PubMed - indexed for MEDLINE]
12.

The treatment challenge of hormone-refractory prostate cancer.

Kish JA, Bukkapatnam R, Palazzo F.

Cancer Control. 2001 Nov-Dec;8(6):487-95. Review.

PMID:
11807418
[PubMed - indexed for MEDLINE]
Free Article
13.

Chemotherapy for advanced prostate cancer: results of new clinical trials and future studies.

Armstrong AJ, Carducci MA.

Curr Oncol Rep. 2005 May;7(3):220-7. Review.

PMID:
15847714
[PubMed - indexed for MEDLINE]
14.

State-of-the-art treatment of metastatic hormone-refractory prostate cancer.

Goodin S, Rao KV, DiPaola RS.

Oncologist. 2002;7(4):360-70. Review.

PMID:
12185298
[PubMed - indexed for MEDLINE]
Free Article
15.

Management of patients with hormone refractory prostate cancer.

Muthuramalingam SR, Patel K, Protheroe A.

Clin Oncol (R Coll Radiol). 2004 Dec;16(8):505-16. Review.

PMID:
15630842
[PubMed - indexed for MEDLINE]
16.

Chemotherapy for prostate cancer.

Gilligan T, Kantoff PW.

Urology. 2002 Sep;60(3 Suppl 1):94-100; discussion 100. Review.

PMID:
12231060
[PubMed - indexed for MEDLINE]
17.
18.

Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.

Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G.

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1023-30. Epub 2007 Jan 23.

PMID:
17242920
[PubMed - indexed for MEDLINE]
19.

Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

Oh WK, Tay MH, Huang J.

Cancer. 2007 Feb 1;109(3):477-86. Review.

PMID:
17186531
[PubMed - indexed for MEDLINE]
Free Article
20.

Management of the spectrum of hormone refractory prostate cancer.

Clarke NW.

Eur Urol. 2006 Sep;50(3):428-38; discussion 438-9. Epub 2006 Jun 2. Review.

PMID:
16797118
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk